79 related articles for article (PubMed ID: 20172413)
21. Chemokines in the pathogenesis of vascular disease.
Charo IF; Taubman MB
Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?
Torre D; Pugliese A
AIDS Rev; 2010; 12(1):31-9. PubMed ID: 20216908
[TBL] [Abstract][Full Text] [Related]
23. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
[TBL] [Abstract][Full Text] [Related]
24. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.
Kline ER; Sutliff RL
J Investig Med; 2008 Jun; 56(5):752-69. PubMed ID: 18525451
[TBL] [Abstract][Full Text] [Related]
25. Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons.
Teofili L; Iachininoto MG; Capodimonti S; Ucciferri C; Nuzzolo ER; Martini M; Torti L; Falasca K; Vecchiet J; Leone G; Larocca LM
AIDS; 2010 Oct; 24(16):2443-50. PubMed ID: 20827169
[TBL] [Abstract][Full Text] [Related]
26. Endothelial dysfunction in HIV infection.
Cotter BR
Curr HIV/AIDS Rep; 2006 Sep; 3(3):126-31. PubMed ID: 16970839
[TBL] [Abstract][Full Text] [Related]
27. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M
Cardiovasc Pathol; 2015; 24(5):279-82. PubMed ID: 26233281
[TBL] [Abstract][Full Text] [Related]
28. [Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients].
Barelli S; Angelillo-Scherrer A; Foguena AK; Periard D; Cavassini M
Rev Med Suisse; 2011 Apr; 7(292):905-10. PubMed ID: 21674894
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease, inflammation, and periodontal infection.
Paquette DW; Brodala N; Nichols TC
Periodontol 2000; 2007; 44():113-26. PubMed ID: 17474929
[No Abstract] [Full Text] [Related]
30. Inflammation in atherosclerosis: a cause or a result of vascular disorders?
Manduteanu I; Simionescu M
J Cell Mol Med; 2012 Sep; 16(9):1978-90. PubMed ID: 22348535
[TBL] [Abstract][Full Text] [Related]
31. Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
Sviridov D; Mukhamedova N; Makarov AA; Adzhubei A; Bukrinsky M
AIDS; 2020 Jan; 34(1):1-13. PubMed ID: 31789888
[TBL] [Abstract][Full Text] [Related]
32. HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.
Pillay B; Ramdial PK; Naidoo DP
Cardiovasc J Afr; 2015; 26(2):70-81. PubMed ID: 25940120
[TBL] [Abstract][Full Text] [Related]
33. Novel Features of Monocytes and Macrophages in Cardiovascular Biology and Disease.
van der Vorst EPC; Weber C
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e30-e37. PubMed ID: 30673349
[No Abstract] [Full Text] [Related]
34. Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
McCutcheon K; Manga P
Thromb Haemost; 2022 Apr; 122(4):476-479. PubMed ID: 34689321
[No Abstract] [Full Text] [Related]
35. [Research progress on dyslipidemia related to human immunodeficiency virus infection].
Li L; Ma P
Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):303-309. PubMed ID: 38448194
[TBL] [Abstract][Full Text] [Related]
36. [Physiopathology of cholesterol].
MOIA B
Rev Asoc Med Argent; 1962 Jan; 76():7-18. PubMed ID: 14475096
[No Abstract] [Full Text] [Related]
37. Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.
Menter DG; Afshar-Kharghan V; Shen JP; Martch SL; Maitra A; Kopetz S; Honn KV; Sood AK
Cancer Metastasis Rev; 2022 Mar; 41(1):147-172. PubMed ID: 35022962
[TBL] [Abstract][Full Text] [Related]
38. [Physiopathology of cardiovascular disease in HIV-infected patients].
Alonso-Villaverde Lozano C
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():33-9. PubMed ID: 20172413
[TBL] [Abstract][Full Text] [Related]
39. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
40. [Immune factors in atherosclerosis].
Pasqui AL; Bova G; Maffei S; Auteri A
Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]